Qiasymphony DSP circulating DNA kit (192) in order to carryout ongoing testing for the adelson project in TNS
Ended Awarded Last action
- Contract number
- 75N95A24F00001
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $11,892
Award facts
- Contract value 100% obligated
- $11,891.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Valencia, CA 91355, USA
Award details come from SAM.gov/FPDS.
About this award
This contract award represents a Blanket Purchase Agreement (BPA) call issued by the National Institute of Neurological Disorders and Stroke (NINDS) to Qiagen, LLC for QIAsymphony DSP Circulating DNA Kits (quantity 192) in support of ongoing testing for the Adelson Project in the Translational Neuroscience Section (TNS). The award, valued at $11,891.56, was issued on April 8, 2024, with an ultimate completion date of July 30, 2024. This is a Firm Fixed Price contract with no set-aside designation, awarded under an existing BPA vehicle that allows Qiagen to efficiently fulfill consumable and equipment needs for the NINDS. The place of performance is Valencia, California, where Qiagen maintains operations for these specialized molecular diagnostics products.
Qiagen, LLC, a foreign-owned, Maryland-headquartered manufacturer specializing in molecular diagnostics and scientific equipment, is well-positioned as a recurring federal contractor across multiple agencies including the National Institutes of Health and Centers for Disease Control and Prevention. The QIAsymphony platform is a widely-used automated liquid handling system for DNA and RNA extraction, making the circulating DNA kits critical consumables for neurological research applications. This procurement supports NINDS's mission to conduct research on neurological disorders and demonstrates Qiagen's continued role in providing essential laboratory reagents and consumables to advance federal biomedical research initiatives.
Quick answers
Who was awarded contract 75N95A24F00001?
75N95A24F00001 was awarded to Qiagen, LLC by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on April 8, 2024.
How much is contract 75N95A24F00001 worth?
The government has obligated $11,892 on 75N95A24F00001.
Is contract 75N95A24F00001 an order under another contract?
Yes. 75N95A24F00001 is a BPA call under HHSN263201500079B, a blanket purchase agreement.
Was contract 75N95A24F00001 competed?
The extent of competition for 75N95A24F00001 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award